Schizophrenia News and Research

Latest Schizophrenia News and Research

Researchers identify two brain phenomena that may explain the side-effects of ketamine

Researchers have identified two brain phenomena that may explain some of the side-effects of ketamine.

11 Jun 2020

Examining dopamine receptors in their natural environment

Dopamine, a chemical that sends messages between different parts of the brain and body, plays a key role in a variety of diseases and behaviors by interacting with receptors on cells.

11 Jun 2020

NMDA receptors play key role in sleep deficits that accompany psychiatric disorders

Sofya Kulikova, a researcher at HSE University in Perm, is part of an international research team that has discovered potential mechanisms that explain the sleep spindle deficit in electroencephalograms (EEG) of people with schizophrenia. The article was published in the Schizophrenia Research on June 5.

5 Jun 2020

Cognitive behavior therapy superior to other psychotherapies at boosting the immune system

A review of 56 randomized clinical trials finds that psychological and behavioral therapies may be effective non-drug treatments for reducing disease-causing inflammation in the body.

3 Jun 2020

High prenatal choline levels may mitigate negative effects of COVID-19 on newborns

Pregnant women who take extra choline supplements may mitigate the negative impact that viral respiratory infections, including COVID-19, can have on their babies, according to a new study from researchers in the Departments of Psychiatry and Obstetrics and Gynecology at the University of Colorado Anschutz Medical Campus.

1 Jun 2020

Out-of-sync gamma waves in the brain may underlie learning issues in psychiatric disorders

A new UC San Francisco study has pinpointed a specific pattern of brain waves that underlies the ability to let go of old, irrelevant learned associations to make way for new updates.

1 Jun 2020

New book series brings updated reviews on diabetes and obesity

Frontiers in Clinical Drug Research - Diabetes and Obesity is a book series that brings updated reviews to readers interested in advances in the development of pharmaceutical agents for the treatment of two metabolic diseases - diabetes and obesity.

27 May 2020

Study paves way to better understand the pathophysiology of schizophrenia

There is an extremely high probability that individuals with 22q11.2 microdeletion syndrome - a rare genetic disorder - will develop schizophrenia together with one of its most common symptoms, auditory hallucinations.

26 May 2020

Can Chlorpromazine help treat COVID-19?

A new research paper published in the journal L'Encéphale in May 2020 reports on the planned ReCoVery Study, which will examine the possibility of repurposing the antipsychotic drug chlorpromazine for the treatment of COVID-19.

25 May 2020

GlobalData: Patients treated for ICU delirium will increase as COVID-19 outbreak continues

An estimated 70–80% of ventilated patients will experience ICU delirium, which causes patients to enter a confused state and can lead to long-term cognitive impairments and memory deficits. GlobalData, therefore, expects to see an increase in the administration of pharmacological treatments for ICU delirium as the COVID-19 outbreak continues.

22 May 2020

Genetic discoveries show promise for developing new treatment targets for schizophrenia

In recent years, genome-wide association studies (GWAS) have identified many different genetic variants associated with schizophrenia.

22 May 2020

Gene variants can increase risk of schizophrenia, shows study

Variants in a gene of the human immune system cause men and women to have different vulnerabilities to the autoimmune diseases lupus and Sjögren's syndrome, according to findings published in the journal Nature.

19 May 2020

Yoga eases depressive symptoms in people with other mental health issues

Researchers have found that the practice of yoga could help those with mental health problems by easing symptoms of depression effectively. Their study titled, "Effects of yoga on depressive symptoms in people with mental disorders: a systematic review and meta-analysis," was published in the latest issue of the British Journal of Sports Medicine. The study was funded by the National Institute for Health Research (NIHR) and Health Education England.

18 May 2020

New treatment discovered to reduce swelling after brain and spinal cord injuries

Scientists have discovered a new treatment to dramatically reduce swelling after brain and spinal cord injuries, offering hope to 75 million victims worldwide each year.

15 May 2020

Study: Neurons expressing dopamine D2 receptors have different molecular features, functions

An international collaboration, which included the involvement of the research team from the Institut de Neurociències of the UAB (INC-UAB), has shown that neurons expressing dopamine D2 receptors have different molecular features and functions, depending on their anatomical localization within the striatum.

14 May 2020

Researchers assess potential impact of COVID-19 on people with psychosis

Researchers at Orygen and La Trobe University in Melbourne, Australia have completed a rapid review of contemporary epidemic and pandemic research to assess the potential impact of COVID-19 on people with psychosis.

13 May 2020

Study provides genetic explanation behind the sex bias observed in certain diseases

Some diseases exhibit a clear sex bias, occurring more often, hitting harder or eliciting different symptoms in men or women.

12 May 2020

Cholesterol lowering drugs can improve composition of gut bacteria in obese individuals

The human gut microbiota consists of trillions of bacteria, fungi and virus constituting an inner chemical factory producing a multitude of microbial compounds affecting immunity, neurobiology and metabolism of the human host.

7 May 2020

Study explores maternal infection and its role in neurodevelopmental disorders

The immune responses of a female mouse before pregnancy can predict how likely her offspring are to have behavioral deficits if the immune system is activated during pregnancy, according to researchers from the Center for Neuroscience at the University of California, Davis.

5 May 2020

Combination of schizophrenia drug and radiation shows promise in treating glioblastoma

Researchers at the UCLA Jonsson Comprehensive Cancer Center and colleagues have found that adding a drug once commonly used to treat schizophrenia to traditional radiation therapy helped improve overall survival in mice with glioblastoma, one of the deadliest and most difficult-to-treat brain tumors.

2 May 2020

Schizophrenia News and Research

Latest Schizophrenia News and Research

Researchers identify two brain phenomena that may explain the side-effects of ketamine

Examining dopamine receptors in their natural environment

NMDA receptors play key role in sleep deficits that accompany psychiatric disorders

Cognitive behavior therapy superior to other psychotherapies at boosting the immune system

High prenatal choline levels may mitigate negative effects of COVID-19 on newborns

Out-of-sync gamma waves in the brain may underlie learning issues in psychiatric disorders

New book series brings updated reviews on diabetes and obesity

Study paves way to better understand the pathophysiology of schizophrenia

Can Chlorpromazine help treat COVID-19?

GlobalData: Patients treated for ICU delirium will increase as COVID-19 outbreak continues

Genetic discoveries show promise for developing new treatment targets for schizophrenia

Gene variants can increase risk of schizophrenia, shows study

Yoga eases depressive symptoms in people with other mental health issues

New treatment discovered to reduce swelling after brain and spinal cord injuries

Study: Neurons expressing dopamine D2 receptors have different molecular features, functions

Researchers assess potential impact of COVID-19 on people with psychosis

Study provides genetic explanation behind the sex bias observed in certain diseases

Cholesterol lowering drugs can improve composition of gut bacteria in obese individuals

Study explores maternal infection and its role in neurodevelopmental disorders

Combination of schizophrenia drug and radiation shows promise in treating glioblastoma

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Schizophrenia News and Research

Latest Schizophrenia News and Research

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in